Шрифт:
Закладка:
4254
Salehi-Pourmehr H, Ostadrahimi A, Ebrahimpour-Mirzarezaei M, Farshbaf-Khalili A. Does aromatherapy with lavender affect physical and psychological symptoms of menopausal women? A systematic review and meta-analysis. Complement Ther Clin Pract. 2020;39:101150. https://pubmed.ncbi.nlm.nih.gov/32379682/
4255
Kazemzadeh R, Nikjou R, Rostamnegad M, Norouzi H. Effect of lavender aromatherapy on menopause hot flushing: a crossover randomized clinical trial. J Chin Med Assoc. 2016;79(9):489–92. https://pubmed.ncbi.nlm.nih.gov/27388435/
4256
Nikjou R, Kazemzadeh R, Asadzadeh F, Fathi R, Mostafazadeh F. The effect of lavender aromatherapy on the symptoms of menopause. J Natl Med Assoc. 2018;110(3):265–9. https://pubmed.ncbi.nlm.nih.gov/29778129/
4257
Dos Reis Lucena L, Dos Santos-Junior JG, Tufik S, Hachul H. Lavender essential oil on postmenopausal women with insomnia: double-blind randomized trial. Complement Ther Med. 2021;59:102726. https://pubmed.ncbi.nlm.nih.gov/33905827/
4258
Donelli D, Antonelli M, Bellinazzi C, Gensini GF, Firenzuoli F. Effects of lavender on anxiety: a systematic review and meta-analysis. Phytomedicine. 2019;65:153099. https://pubmed.ncbi.nlm.nih.gov/31655395/
4259
Farshbaf-Khalili A, Kamalifard M, Namadian M. Comparison of the effect of lavender and bitter orange on anxiety in postmenopausal women: a triple-blind, randomized, controlled clinical trial. Complement Ther Clin Pract. 2018;31:132–8. https://pubmed.ncbi.nlm.nih.gov/29705445/
4260
Kamalifard M, Farshbaf-Khalili A, Namadian M, Ranjbar Y, Herizchi S. Comparison of the effect of lavender and bitter orange on sleep quality in postmenopausal women: a triple-blind, randomized, controlled clinical trial. Women Health. 2018;58(8):851–65. https://pubmed.ncbi.nlm.nih.gov/28749734/
4261
Latiff LA, Parhizkar S, Dollah MA, Hassan STS. Alternative supplement for enhancement of reproductive health and metabolic profile among perimenopausal women: a novel role of Nigella sativa. Iran J Basic Med Sci. 2014;17(12):980–5. https://pubmed.ncbi.nlm.nih.gov/25859301/
4262
Rahimi Kian F, Bekhradi R, Rahimi R, Golzareh P, Mehran A. Evaluating the effect of fennel soft capsules on the quality of life and its different aspects in menopausal women: a randomized clinical trial. Nurs Pract Today. 2017;4(2):87–95. https://www.researchgate.net/publication/319183067_Evaluating_the_effect_of_fennel_soft_capsules_on_the_quality_of_life_and_its_different_aspects_in_menopausal_women_A_randomized_clinical_trial_ARTICLE_INFO_ABSTRACT
4263
Khan TM, Wu DBC, Dolzhenko AV. Effectiveness of fenugreek as a galactagogue: a network meta-analysis. Phytother Res. 2018;32(3):402–12. https://pubmed.ncbi.nlm.nih.gov/29193352/
4264
Hakimi S, Charandabi SMA, Shadbad MRS, et al. Effect of Fenugreek seed on early menopausal symptoms. Pharm Sci. 2005;(2):83–90. https://www.researchgate.net/publication/236619683_Effect_of_Fenugreek_seed_on_early_menopausal_symptoms
4265
Tariq SH, Haren MT, Kim MJ, Morley JE. Andropause: is the emperor wearing any clothes? Rev Endocr Metab Disord. 2005;6(2):77–84. https://pubmed.ncbi.nlm.nih.gov/15843878/
4266
Saad F, Gooren LJ. Late onset hypogonadism of men is not equivalent to the menopause. Maturitas. 2014;79(1):52–7. https://pubmed.ncbi.nlm.nih.gov/25042874/
4267
Tariq SH, Haren MT, Kim MJ, Morley JE. Andropause: is the emperor wearing any clothes? Rev Endocr Metab Disord. 2005;6(2):77–84. https://pubmed.ncbi.nlm.nih.gov/15843878/
4268
Swee DS, Gan EH. Late-onset hypogonadism as primary testicular failure. Front Endocrinol (Lausanne). 2019;10:372. https://pubmed.ncbi.nlm.nih.gov/31244778/
4269
Vitry AI, Mintzes B. Disease mongering and low testosterone in men: the tale of two regulatory failures. Med J Aust. 2012;196(10):619–21. https://pubmed.ncbi.nlm.nih.gov/22676868/
4270
Schwartz LM, Woloshin S. Low “T” as in “template”: how to sell disease. JAMA Intern Med. 2013;173(15):1460–2. https://pubmed.ncbi.nlm.nih.gov/23939516/
4271
Perls T, Handelsman DJ. Disease mongering of age-associated declines in testosterone and growth hormone levels. J Am Geriatr Soc. 2015;63(4):809–11. https://pubmed.ncbi.nlm.nih.gov/25809947/
4272
Eder S. Many players in the concerto of sex. Science. 2007;315(5817):1370. https://www.science.org/doi/abs/10.1126/science.1139058
4273
Shomali ME. The use of anti-aging hormones. Melatonin, growth hormone, testosterone, and dehydroepiandrosterone: consumer enthusiasm for unproven therapies. Md Med J. 1997;46(4):181–6. https://pubmed.ncbi.nlm.nih.gov/9114695/
4274
Rengachary SS, Colen C, Guthikonda M. Charles-Édouard Brown-Séquard: an eccentric genius. Neurosurgery. 2008;62(4):954–64. https://pubmed.ncbi.nlm.nih.gov/18496202/
4275
Kim MJ, Morley JE. The hormonal fountains of youth: myth or reality? J Endocrinol Invest. 2005;28(11 Suppl Proceedings):5–14. https://pubmed.ncbi.nlm.nih.gov/16760618/
4276
Swee DS, Gan EH. Late-onset hypogonadism as primary testicular failure. Front Endocrinol (Lausanne). 2019;10:372. https://pubmed.ncbi.nlm.nih.gov/31244778/
4277
Sartorius G, Spasevska S, Idan A, et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf). 2012;77(5):755–63. https://pubmed.ncbi.nlm.nih.gov/22563890/
4278
Saad F, Gooren LJ. Late onset hypogonadism of men is not equivalent to the menopause. Maturitas. 2014;79(1):52–7. https://pubmed.ncbi.nlm.nih.gov/25042874/
4279
Busnelli A, Somigliana E, Vercellini P. ‘Forever young’—testosterone replacement therapy: a blockbuster drug despite flabby evidence and broken promises. Human Reproduction. 2017;32(4):719–24. https://pubmed.ncbi.nlm.nih.gov/28333214/
4280
Handelsman DJ. Irrational exuberance in testosterone prescribing: when will the bubble burst? Med Care. 2015;53(9):743–5. https://pubmed.ncbi.nlm.nih.gov/26270825/
4281
Perls T, Handelsman DJ. Disease mongering of age-associated declines in testosterone and growth hormone levels. J Am Geriatr Soc. 2015;63(4):809–11. https://pubmed.ncbi.nlm.nih.gov/25809947/
4282
Vitry AI, Mintzes B. Disease mongering and low testosterone in men: the tale of two regulatory failures. Med J Aust. 2012;196(10):619–21. https://pubmed.ncbi.nlm.nih.gov/22676868/
4283
Mintzes B. The marketing of testosterone treatments for age-related low testosterone or “Low T.” Curr Opin Endocrinol Diabetes Obes. 2018;25(3):224–30. https://pubmed.ncbi.nlm.nih.gov/29570470/
4284
Morley JE, Perry HM III, Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas. 2006;53(4):424–9. https://pubmed.ncbi.nlm.nih.gov/16140484/
4285
Vitry AI, Mintzes B. Disease mongering and low testosterone in men: the tale of two regulatory failures. Med J Aust. 2012;196(10):619–21. https://pubmed.ncbi.nlm.nih.gov/22676868/
4286
Dunn M, Mulrooney KJ, Forlini C, van de Ven K, Underwood M. The pharmaceuticalisation of “healthy” ageing: testosterone enhancement for longevity. Int J Drug Policy. 2021;95:103159. https://pubmed.ncbi.nlm.nih.gov/33583680/
4287
Fugh-Berman A, Hogenmiller A.
